Join ReciBioPharm at the mRNA Based-Therapeutics summit, taking place January 23-25, 2024 in Berlin, Germany.
ReciBioPharm combines the capabilities of CDMOs Arranta Bio, GenIbet, and Vibalogics as a trusted partner for biologics drug development and manufacturing services.
With our expanded portfolio of cutting-edge technologies and expertise, we offer a comprehensive suite of solutions to accelerate the production of complex therapeutics such as plasmid DNA, RNA-based therapies, and viral-based vaccines.
Innovation is at the heart of ReciBioPharm, exploring uncharted territories in drug development. By forging strategic partnerships with leading biotech companies, we accelerate the translation of scientific discoveries into tangible clinical solutions.
Meet us at the 3rd mRNA Based-Therepeutics Summit Europe to discover first-hand how we are shaping the future of medicine and empowering healthcare providers with ground-breaking therapies that revolutionise the way we approach drug development.